Investigational Study of the Ekso Bionics Powered Exoskeleton for High-Dosage Use by Individuals With SCI in a Non-Clinical Environment
Status: | Enrolling by invitation |
---|---|
Conditions: | Hospital, Orthopedic |
Therapuetic Areas: | Orthopedics / Podiatry, Other |
Healthy: | No |
Age Range: | 18 - 65 |
Updated: | 2/15/2018 |
Start Date: | January 2014 |
End Date: | January 2019 |
Investigational Study of the Ekso Bionics Powered Exoskeleton for High-Dosage Use by Individuals With Spinal Cord Injury in a Non-Clinical Environment
The purpose of the study is to study the safety and health effects of using the Ekso Bionics
powered exoskeleton device in a home setting over a 12-36 month period.
powered exoskeleton device in a home setting over a 12-36 month period.
This is a 36 month exploratory Investigational Study compliant with the NSF Human Subjects
regulations (45 CFR 690) trialing a new device for the SCI populations to aid in ambulatory
function in a home setting. Ekso Bionics will enable up to twelve (12) subjects with SCI to
use an Ekso device in their home for a 12-month period. Qualified subjects will help Ekso
Bionics determine the practical use of the device in the home environment and will enable
Ekso Bionics to gather data to develop a device for use in a home environment. The study will
require a trained spotter to be present at all times that the device is being used. The study
will also evaluate the effectiveness of a non-medically licensed spotter to assist the
subject.
regulations (45 CFR 690) trialing a new device for the SCI populations to aid in ambulatory
function in a home setting. Ekso Bionics will enable up to twelve (12) subjects with SCI to
use an Ekso device in their home for a 12-month period. Qualified subjects will help Ekso
Bionics determine the practical use of the device in the home environment and will enable
Ekso Bionics to gather data to develop a device for use in a home environment. The study will
require a trained spotter to be present at all times that the device is being used. The study
will also evaluate the effectiveness of a non-medically licensed spotter to assist the
subject.
Inclusion Criteria:
- be an experienced user of the Ekso device with a minimum of 20 hours and no more than
50 hours of device use and require no greater than minimal assist (support of up to
25% body weight) for safe and consistent walking.
- no more than 2 episodes of balance loss per 1 hour training session that require no
more than moderate assistance (support of 26% to 50% of body weight)
- participants with more than 50 hours of device experience must agree to a 1 month
period of non-use prior to acquisition of baseline measures
- be between 18-65 years of age.
- be able to physically fit into the exoskeleton device.
- be able to tolerate upright standing for up to 60 minutes.
- have sufficient joint range of motion to fit safely within Ekso: Hip flexion
contracture ≤ 15o; knee flexion contracture ≤ 10o; ankle dorsiflexion to neutral with
no more than 10o of knee flexion.
- have sufficient upper body strength to balance themselves with two arms
- be fluent in English
Exclusion Criteria:
- Height below 60 inches or above 76 inches or with physical characteristics
incompatible with device and testing procedure.
- Weight above 220 lbs.
- Lower extremity joint contractures that exceed device capacity for safe use.
- Any medical issue that precludes full weight bearing and ambulation (e.g. osteoporosis
that prevents safe standing, orthopedic injuries, pain, severe spasticity)
- Skin integrity issues that would prevent wearing the device.
- Cognitive and/or communicative disability inappropriate for testing as determined by
Ekso Bionics clinician. Subjects must be able to follow directions well and
demonstrate learning capability.
- Pregnancy (Self-reported)
- Colostomy
- Medical or environmental conditions arising after the start of the study that are
deemed unsafe per Ekso Bionics discretion.
We found this trial at
1
site
Click here to add this to my saved trials